Home Data Calendar Blog

MNKD

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Common Stock Value 2.692.682.642.642.632.572.522.52NA2.502.492.422.312.292.132.122.061.891.881.871.591.461.261.191.051.050.964.784.784.784.294.294.184.124.094.064.053.963.873.702.862.001.991.681.311.311.31NA1.28NANA
Weighted Average Number Of Diluted Shares Outstanding 323.77265.63263.97NA259.30253.64251.89NA249.91249.29NANANANANANANANANA161.40153.60140.05120.91116.45104.7099.8695.7496.51482.7491.0685.77NA405.20NANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 268.73265.63263.97NA259.30253.64251.89NA249.91249.29NANANANANANANANANA161.40153.60140.05120.91116.45104.7099.8695.7495.68478.1491.0685.77NA405.20NANANANANANANANANANANANANANANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANANANANANA251.89NANA249.29246.63NA229.67213.88212.47206.69199.91188.05187.43161.40153.60140.05120.91NA104.7099.8695.74NANA455.31428.8683.86405.20401.02398.92NA394.16380.77368.78NANANANANANANANANANANANA
Earnings Per Share Basic 0.01-0.02-0.04-0.07-0.06-0.11-0.10-0.11-0.02-0.14NANANANANANANANANA-0.06-0.16-0.16-0.25-0.28-0.31-0.35-0.170.560.26-0.33-0.29-4.31-0.08NANANANANANANANANANANANANANANANANANA
Earnings Per Share Diluted 0.01-0.02-0.04-0.07-0.06-0.11-0.10-0.11-0.02-0.14NANANANANANANANANA-0.06-0.16-0.16-0.25-0.28-0.31-0.35-0.170.560.26-0.33-0.29-4.31-0.08NANANANANANANANANANANANANANANANANANA
Earnings Per Share Basic And Diluted NANANANANANA-0.10NANA-0.14-0.05-0.12-0.05-0.05-0.04-0.07-0.05-0.07-0.08-0.06-0.16-0.16-0.25NA-0.31-0.35-0.17NANA-0.07-0.06-0.66-0.08-0.07-0.08-0.09-0.09-0.19-0.14-0.16-0.23-0.22-0.23-0.27-0.30-0.31-0.37-0.34-0.33-0.40-0.37

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenue From Contract With Customer Excluding Assessed Tax 51.2548.6140.6336.0632.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Revenues 51.2548.6140.6336.0632.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cost Of Goods And Services Sold 4.005.225.534.085.024.622.284.293.814.414.323.653.593.684.164.637.104.334.025.005.305.094.015.024.585.09NANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Expenses 14.2514.2416.2116.1217.4612.9111.0011.439.899.93NANANANANANANANANANANANANANANANANANANANA20.01272.8626.0024.0521.7430.1038.2769.8541.4146.6233.4935.5244.0533.9330.5832.7739.1938.0532.0942.5437.36
Costs And Expenses 46.1646.8946.6248.8542.4439.3533.2536.4828.8033.5523.6342.1924.4823.0323.3627.3423.3725.9530.9623.7626.0124.4330.2533.3730.2233.7322.6124.2444.1219.1220.01272.8626.0024.05NANANANANANANANANANANANANANANANANA
Research And Development Expense Excluding Acquired In Process Cost 9.996.455.617.164.144.893.543.893.652.332.441.541.481.461.752.021.581.631.671.082.042.972.643.514.363.123.131.563.924.315.136.226.347.749.3817.5619.1837.3226.1828.9925.2725.4526.6424.1620.2423.1330.3026.2924.2231.4126.16
General And Administrative Expense 10.5411.9510.5410.489.1010.187.97NANANANANANANANANANANANANANANANANANANANA6.506.13NA7.358.3111.5510.6210.4812.5419.0932.5215.2317.638.2110.0717.429.7810.349.648.8911.767.8811.1311.20
Selling General And Administrative Expense NANANANA22.6426.0420.7022.7317.2220.0617.4117.1213.9013.6714.3515.7216.6716.6125.6717.9819.3921.7320.6223.2817.7318.5715.3915.3313.1311.117.358.3111.5510.62NANANANANANANANANANANANANANANANANA
Operating Income Loss 5.101.72-6.00-12.79-9.61-20.45-21.26-23.97-6.59-10.27-6.19-23.75-9.13-7.92-7.12-11.35-8.78-10.95-13.51-7.73-21.54-20.54-26.79-28.84-28.18-31.57-19.60-11.83118.23-19.12-20.01-272.86-26.00-24.05-21.74-30.10-38.27-69.85-41.41-46.62-33.49-35.49-44.05-33.93-30.58-32.77-39.19-38.00-32.09-42.54-37.26
Interest Expense 2.816.872.422.422.816.642.37NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Interest Expense Debt NANA2.792.812.816.642.752.772.802.815.421.101.061.081.071.024.130.560.590.620.991.711.792.062.312.422.713.014.174.184.223.334.144.139.625.655.422.434.045.102.862.862.842.582.852.852.832.412.831.881.21
Interest Paid Net 3.720.563.703.710.800.743.600.733.825.621.090.701.040.940.89NANANANA0.861.030.001.861.352.231.592.551.792.591.902.711.924.79NANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 4.605.583.652.603.624.422.813.163.183.931.941.901.292.191.130.891.642.571.001.141.562.211.941.081.251.251.301.001.501.351.272.352.601.772.001.87-4.8340.6410.9413.883.523.823.072.883.183.321.99NANANANA
Profit Loss 1.72-5.26-9.79-17.95-14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.16-22.68-30.39-32.78-32.89NANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss 1.72-5.26-9.79-17.95-14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.39-32.78-32.89-35.34-16.3253.98126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.52-73.36-52.06-53.58-51.78-42.83-36.58-38.17-36.40-38.40-44.48-41.52-38.31-45.30-42.25
Comprehensive Income Net Of Tax 1.72-4.82-9.79-16.74-14.43-29.15-27.07-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.34-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.38-32.78-32.88-35.34-16.3253.97126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.53-73.36-52.06-53.58-51.79-42.84-36.57-38.13-36.40-38.40-44.53-41.54NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets 320.33313.42298.14295.28293.84285.80308.32321.16NA252.79319.38108.6195.68102.7880.2193.7295.1481.80100.96107.7045.3662.1661.8884.5856.4879.3785.19107.0696.13139.4393.27126.41278.01352.55360.02394.44386.82236.31224.55258.65251.31210.33240.39251.42199.55224.01228.36NA277.26NANA
Liabilities 572.11573.91553.53545.82531.51532.85540.38530.51NA436.34493.00289.03282.10282.49278.26284.25279.85277.79288.96282.79250.80268.77285.08299.31307.50300.62283.91290.66334.82506.01466.74476.74402.58468.03457.05468.21427.50282.68207.02289.36361.99486.58484.77528.81513.21504.82473.74NA462.79NANA
Liabilities And Stockholders Equity 320.33313.42298.14295.28293.84285.80308.32321.16NA252.79319.38108.6195.68102.7880.2193.7295.1481.80100.96107.7045.3662.1661.8884.5856.4879.3785.19107.0696.13139.4393.27126.41278.01352.55360.02394.44386.82236.31224.55258.65251.31210.33240.39251.42199.55224.01228.36NA277.26NANA
Stockholders Equity -251.78-260.49-255.40-250.54-237.68-247.06-232.06-209.35-184.69-183.55-173.62-180.42-186.42-179.71-198.05-190.53-184.71-196.00-188.00-175.08-205.44-206.62-223.21-214.73-251.01-221.24-198.72-183.59-238.69-366.58-373.46-350.33-124.57-115.47-97.03-73.77-40.68-46.3817.54-30.71-110.68-276.25-244.38-277.39-313.65-280.81-245.38NA-185.53NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Assets Current 225.57230.23223.30234.90218.38193.48184.26219.74NA179.90288.3479.4866.3572.5849.3560.7661.7449.8369.6981.8519.5235.8035.0357.2228.6350.9356.0977.4948.6090.7644.1476.6571.24145.83158.29201.15193.5244.9139.4076.2866.8123.2050.3459.715.8227.0226.86NA73.95NANA
Cash And Cash Equivalents At Carrying Value 83.0286.1885.8769.7754.3135.5167.24124.18NA62.52247.8367.0052.4063.2238.8729.9130.177.9734.5371.1610.4526.1826.7143.9520.0943.3847.9822.8935.5363.7327.6559.0732.93107.19120.84120.84172.4741.2135.7670.7961.841.7631.6456.352.6822.7924.7746.9166.0697.9328.36
Short Term Investments 58.0058.1680.27101.08110.74118.6595.2079.93NA99.9728.96NANA0.000.0019.9819.8924.9124.76NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accounts Receivable Net Current 21.8227.7919.7116.8023.4915.039.824.99NA6.303.574.224.133.375.033.514.094.973.764.022.752.851.552.791.801.310.440.303.14NA0.140.021.684.754.2850.44NANANANANANANANANANANANANANANA
Inventory Net 27.1225.2922.0021.7718.2720.578.047.15NA7.485.054.974.883.823.234.163.693.963.723.602.793.683.892.663.133.173.702.33NANANANA23.4019.8216.799.67NANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 35.6232.8115.4525.4811.573.723.953.48NA3.622.773.124.621.861.902.893.582.702.392.563.022.572.353.013.062.563.514.364.531.422.814.0213.2314.0816.3820.2120.253.703.645.494.5221.0818.363.002.622.961.59NA2.85NANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Property Plant And Equipment Gross 181.70169.73154.39143.69140.30136.48139.36134.27NA125.46123.34122.69122.36122.36122.28122.14128.76128.38126.61126.10127.36127.42127.42127.87128.08128.39128.50128.50167.44167.44167.46308.67316.76317.02314.00310.35309.07299.33289.92287.62285.21286.08285.39NA284.79NANANANANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 101.28100.2299.5598.5699.1298.5697.9197.66NA97.3296.8496.8296.6296.1795.7795.36101.63101.24100.86100.50101.73101.39100.94100.95100.70100.47100.0299.58120.62120.02119.43119.51125.35123.15120.55118.22118.15115.80113.58111.06101.2599.4796.24NA91.76NANANANANANA
Property Plant And Equipment Net 80.4169.5154.8445.1341.1837.9241.4536.61NA28.1426.5125.8725.7426.1926.5226.7827.1327.1525.7525.6025.6326.0426.4826.9227.3727.9228.4828.9346.8347.4248.0348.75191.41193.87193.45192.13190.92183.53176.34176.56183.96186.61189.16190.92193.03196.37200.38NA202.36NANA
Long Term Investments 3.272.280.491.9612.7332.6070.5456.62NA38.951.48NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Goodwill 1.931.932.002.433.072.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Intangible Assets Net Excluding Goodwill 1.091.111.131.151.171.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 8.058.3516.389.7217.3117.5112.068.19NA5.803.053.273.604.014.356.19NANANA0.250.200.320.370.440.480.520.610.650.701.251.101.011.832.022.030.852.117.408.445.520.230.230.230.230.230.230.23NA0.32NANA
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value 3.262.260.501.95NANANA56.43NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Held To Maturity Securities Debt Maturities Within One Year Fair Value 126.60132.86154.31156.98NANANA103.67NANANA59.49NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Liabilities Current 96.3796.9781.8567.3059.6059.5653.4948.35NA60.4373.1273.70106.1267.9468.2565.6264.2976.9877.8775.2459.6374.9080.6787.6091.4785.8793.0592.05105.83289.71249.21268.32267.31342.25380.75403.35293.78119.2344.52127.79144.7851.7655.4434.4125.3617.3121.56NA18.13NANA
Accounts Payable Current 16.7517.1313.8911.059.877.828.706.96NA7.496.715.585.805.826.734.7911.667.536.985.385.829.244.986.985.286.541.523.265.092.850.5815.604.445.193.307.3917.395.093.643.864.553.175.822.664.621.601.60NA3.29NANA
Other Accrued Liabilities Current 3.404.113.454.722.983.332.471.98NA1.561.200.860.800.590.861.300.371.570.981.030.811.070.960.590.720.500.800.350.203.112.191.413.093.043.397.5412.274.215.725.711.301.491.72NA1.09NANANANANANA
Accrued Liabilities Current 32.1036.8332.9935.5530.3533.1827.1327.42NA22.4127.5919.7115.8114.7118.3315.9014.3016.4518.0615.0213.4314.0715.9312.4512.499.0810.667.9414.1610.258.087.9314.0813.9312.3826.2127.2720.5815.0121.6325.7848.6049.6231.7520.7415.7119.96NA14.84NANA
Contract With Customer Liability Current 3.673.492.321.731.791.671.310.83NA20.1325.8833.2728.8732.1830.8432.5032.2132.3732.3836.88NANANA0.25NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Long Term Debt 273.24274.43273.96273.49273.02272.55281.67281.20NA285.13330.59122.23121.83121.75119.02118.90118.7799.99102.49102.49105.48129.36140.27156.82NANANANANANANANANA244.90232.50NANANANANANANANANANANANANANANANA
Senior Notes 226.49226.12225.76225.40225.03224.67224.31223.94NA223.22222.85NANANANA10.03NANANA19.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent NANANANANANA7.054.95NA5.32NANANANANANANANANANANANANANANANANANA17.4016.6715.9515.2214.4912.1226.7815.3411.5715.0414.3213.61NANANANANANANANANANANA
Operating Lease Liability Noncurrent 4.294.654.885.345.675.930.831.04NA0.560.871.201.521.842.152.512.753.093.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Stockholders Equity -251.78-260.49-255.40-250.54-237.68-247.06-232.06-209.35-184.69-183.55-173.62-180.42-186.42-179.71-198.05-190.53-184.71-196.00-188.00-175.08-205.44-206.62-223.21-214.73-251.01-221.24-198.72-183.59-238.69-366.58-373.46-350.33-124.57-115.47-97.03-73.77-40.68-46.3817.54-30.71-110.68-276.25-244.38-277.39-313.65-280.81-245.38NA-185.53NANA
Common Stock Value 2.692.682.642.642.632.572.522.52NA2.502.492.422.312.292.132.122.061.891.881.871.591.461.261.191.051.050.964.784.784.784.294.294.184.124.094.064.053.963.873.702.862.001.991.681.311.311.31NA1.28NANA
Additional Paid In Capital Common Stock 2975.892968.922969.222964.292960.422936.672922.552918.20NA2911.532885.952866.302834.002829.482801.042799.282790.892769.402765.022763.072723.232698.032658.962638.992570.072566.962554.232549.212548.092546.732510.372508.632457.482434.782424.352416.972413.622371.492362.132262.001991.381774.891763.941694.661620.541616.981614.02NA1587.86NANA
Retained Earnings Accumulated Deficit -3230.81-3232.53-3227.26-3217.47-3199.52-3185.09-3156.07-3130.07NA-3097.58-3062.06-3049.14-3022.73-3011.48-3001.22-2991.90-2977.64-2967.27-2954.88-2940.00-2930.25-2906.09-2883.41-2854.90-2822.11-2789.23-2753.89-2737.57-2791.54-2918.06-2888.10-2863.23-2586.21-2554.35-2525.45-2494.78NANANA-2296.40NANANANANANANANANANANA
Accumulated Other Comprehensive Income Loss Net Of Tax 0.440.44NANA-1.21-1.21-1.08NANANANANANANANA-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.01-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.02-0.01-0.01-0.00-0.00-0.00-0.01-0.01-0.01-0.000.040.040.04NA0.07NANA
Stock Issued During Period Value New Issues 4.11NANANA19.79NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 4.605.583.65NA3.624.422.81NA3.183.931.94NA1.292.191.13NA1.642.571.00NA1.562.211.94NANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities 8.662.601.16-2.38-28.07-31.98-18.25-12.35-15.18-21.45-12.730.23-13.46-3.68-11.22-5.11-52.05-19.73-11.6024.99-13.92-27.15-21.65-29.98-23.27NANANANANANANANANANANANANANA-34.05-28.10-34.26-25.02-32.49-20.36-36.03-36.74-30.70-38.97-34.85NA
Net Cash Provided By Used In Investing Activities -11.553.6613.7915.0127.352.02-39.51-12.584.99-112.53-31.42-4.48-0.00-0.1519.85-0.203.76-1.37-25.03-0.24NANANA0.00NANANANANANANANANANANANANANANA-6.17-0.06-0.12-0.08-0.29-0.12-0.59-4.051.83-8.110.45NA
Net Cash Provided By Used In Financing Activities -0.28-5.951.152.8319.53-1.780.8197.37-0.59-51.49224.9818.692.6428.190.335.0465.50-0.680.0035.97-1.8226.620.5358.24-0.02NANANANANANANANANANANANANANA17.2088.234.510.3986.450.3834.6518.659.7215.22103.97NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Operating Activities 8.662.601.16-2.38-28.07-31.98-18.25-12.35-15.18-21.45-12.730.23-13.46-3.68-11.22-5.11-52.05-19.73-11.6024.99-13.92-27.15-21.65-29.98-23.27NANANANANANANANANANANANANANA-34.05-28.10-34.26-25.02-32.49-20.36-36.03-36.74-30.70-38.97-34.85NA
Net Income Loss 1.72-5.26-9.79-17.95-14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.17-22.68-30.39-32.78-32.89-35.34-16.3253.98126.52-29.96-24.87-277.02-31.86-28.91-30.66-36.44-36.52-73.36-52.06-53.58-51.78-42.83-36.58-38.17-36.40-38.40-44.48-41.52-38.31-45.30-42.25
Profit Loss 1.72-5.26-9.79-17.95-14.43-29.02-26.00-28.06-4.43-35.52-12.92-26.41-11.26-10.25-9.32-14.26-10.37-12.39-14.88-9.75-24.16-22.68-30.39-32.78-32.89NANANANANANANANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Receivable -5.978.072.91-6.698.465.214.83-4.453.142.73-0.650.080.77-1.811.66-0.58-0.881.22-0.261.26-0.101.30-1.130.980.490.870.14-2.813.14-0.140.12NANANANANANANANANANANANANANANANANANANANA
Increase Decrease In Inventories 2.134.242.644.33-1.381.830.891.570.002.430.080.091.060.59-0.430.46-0.270.240.121.230.12-0.041.842.50-0.04-0.531.37-2.792.26NANA12.703.59NANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -0.373.242.841.182.05-0.881.75-2.572.040.781.12-0.21-0.02-0.911.94-6.884.130.561.60-0.44-3.424.26-2.011.70-1.265.02-1.67-1.832.242.27-14.8011.11-0.461.95-4.18-10.0712.122.60-1.040.861.57-2.772.96-1.712.790.33-0.23-0.22-4.253.77NA
Share Based Compensation 4.605.583.652.603.624.422.813.163.183.931.941.901.292.191.130.891.642.671.001.141.562.211.941.081.251.251.271.001.501.351.272.352.601.772.001.87-4.8340.6510.9413.883.523.823.072.883.183.321.992.712.243.34NA
Amortization Of Financing Costs 0.360.360.36NA0.360.360.36NANA0.360.12NA0.030.030.03NA0.030.020.010.010.010.010.01-0.010.010.020.01NANANANANANANANANANANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Investing Activities -11.553.6613.7915.0127.352.02-39.51-12.584.99-112.53-31.42-4.48-0.00-0.1519.85-0.203.76-1.37-25.03-0.24NANANA0.00NANANANANANANANANANANANANANANA-6.17-0.06-0.12-0.08-0.29-0.12-0.59-4.051.83-8.110.45NA
Payments To Acquire Property Plant And Equipment 11.3916.878.315.100.27-2.835.065.194.251.050.980.500.000.150.150.110.961.220.27NANANANANANANANA0.000.000.001.140.321.234.534.204.969.478.261.416.170.070.120.120.320.150.594.121.993.941.55NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Net Cash Provided By Used In Financing Activities -0.28-5.951.152.8319.53-1.780.8197.37-0.59-51.49224.9818.692.6428.190.335.0465.50-0.680.0035.97-1.8226.620.5358.24-0.02NANANANANANANANANANANANANANA17.2088.234.510.3986.450.3834.6518.659.7215.22103.97NA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30
Revenues 51.2548.6140.6336.0632.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cipla Ltd, License And Service, License And Distribution Agreement 0.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.04NA0.040.03NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma, License And Service, Co Promotion Agreement NANANANA0.000.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma L L C, License And Service, Co Promotion Agreement NANANA0.000.000.30NA0.000.000.860.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product Sales 30.7329.2828.7326.4726.1817.4210.5211.619.759.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service 13.1111.2111.399.5410.355.872.171.1812.4613.309.348.388.088.138.238.238.198.9412.3710.350.080.090.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 17.9318.3417.5617.4416.2612.729.8311.349.759.988.1010.067.286.998.007.766.406.075.085.734.393.753.404.471.981.55NANANANANANANANANANANANANANANANANANANANANANANANANA
Royalty 20.2219.0511.689.076.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Service 0.310.280.220.510.431.171.470.9112.4613.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement 12.8010.9311.16NA9.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement 0.270.240.18NA0.390.701.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement NANANA9.039.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement NANANA0.480.390.701.350.6712.3112.169.008.287.987.987.987.977.867.787.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Agreement NANANA0.00-0.000.110.090.160.080.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation 33.2930.2323.0318.5816.535.702.040.9412.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Commercial Supply Agreement 12.8010.9311.169.039.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, License Agreement 0.270.240.180.480.390.701.350.6712.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Royalties Arrangement 20.2219.0511.689.076.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 51.2548.6140.6336.0632.8318.8911.9912.5222.2123.2817.4418.4415.3515.1116.2315.9914.6015.0017.4516.034.473.893.464.532.042.163.0112.40162.350.000.000.000.000.000.000.000.000.000.000.000.000.040.000.000.000.000.000.050.000.000.09
Cipla Ltd, License And Service, License And Distribution Agreement 0.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.040.04NA0.040.03NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma, License And Service, Co Promotion Agreement NANANANA0.000.33NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Vertice Pharma L L C, License And Service, Co Promotion Agreement NANANA0.000.000.30NA0.000.000.860.29NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product Sales 30.7329.2828.7326.4726.1817.4210.5211.619.759.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service 13.1111.2111.399.5410.355.872.171.1812.4613.309.348.388.088.138.238.238.198.9412.3710.350.080.090.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 17.9318.3417.5617.4416.2612.729.8311.349.759.988.1010.067.286.998.007.766.406.075.085.734.393.753.404.471.981.55NANANANANANANANANANANANANANANANANANANANANANANANANA
Royalty 20.2219.0511.689.076.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Service 0.310.280.220.510.431.171.470.9112.4613.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement 12.8010.9311.16NA9.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement 0.270.240.18NA0.390.701.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, Commercial Supply Agreement NANANA9.039.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, United Therapeutics Corporation, License Agreement NANANA0.480.390.701.350.6712.3112.169.008.287.987.987.987.977.867.787.62NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License And Service, Other Agreement NANANA0.00-0.000.110.090.160.080.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation 33.2930.2323.0318.5816.535.702.040.9412.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Commercial Supply Agreement 12.8010.9311.169.039.924.700.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, License Agreement 0.270.240.180.480.390.701.350.6712.3112.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
United Therapeutics Corporation, Royalties Arrangement 20.2219.0511.689.076.220.30NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Other Nonoperating Income Expense
Balance Sheet
Stockholders Equity
Assets
Intangible Assets Net Excluding Goodwill
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Intangible Assets Net Excluding Goodwill
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Accounts Receivable
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
InventoryNet
Inventory Raw Materials Net Of Reserves
AccountsReceivable
Allowance For Doubtful Accounts Receivable Current

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'us-gaap:LicenseAndService', 'mnkd:CoPromotionAgreement')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransaction, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transaction, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'us-gaap:LicenseAndService', 'mnkd:CoPromotionAgreement')
Revenuesus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransaction, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transaction, us-gaap: Type Of Arrangement
us-gaap:OperatingExpenses
us-gaap:ProductOrService
(None,)
Operating Expensesus-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:AwardType
(None,)
Allocated Share Based Compensation Expenseus-gaap: Award Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AccountsReceivableNetCurrent
us-gaap:ProductOrService
(None,)
Accounts Receivable Net Currentus-gaap: Product Or Service
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockIssuedDuringPeriodValueNewIssues
us-gaap:StatementEquityComponents
(None,)
Stock Issued During Period Value New Issuesus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'us-gaap:LicenseAndService', 'mnkd:CoPromotionAgreement')
Revenuesus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:Revenues
us-gaap:ProductOrService, us-gaap:RelatedPartyTransaction, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenuesus-gaap: Product Or Service, us-gaap: Related Party Transaction, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService, us-gaap:TypeOfArrangement
(None, 'us-gaap:LicenseAndService', 'mnkd:CoPromotionAgreement')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Counterparty Name, us-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:TypeOfArrangement
('mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Related Party Transactions By Related Party, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:RelatedPartyTransaction, us-gaap:TypeOfArrangement
('us-gaap:LicenseAndService', 'mnkd:UnitedTherapeuticsCorporation', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Related Party Transaction, us-gaap: Type Of Arrangement